pathway Info Card

Type 2 Immune Response

Information about Type 2 Immune Response: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Type 2 Immune Response

Most recent studies have shown that Type 2 Immune Response shares some biological mechanisms with adaptive-immune-response, cell-differentiation, cell-proliferation, chemokine-production, chemotaxis, cytokine-production, cytokine-secretion, fibroblast-proliferation, germinal-center-formation, hypersensitivity, immune-response, inflammatory-response, interferon-gamma-secretion, isotype-switching, pathogenesis, protein-secretion, secretion, t-cell-differentiation, tolerance-induction, virulence.

Among the many pathways, these few ones have gauged particular interests from scientists studying Type 2 Immune Response, and have been seen in publications frequently: adaptive-immune-response, cell-differentiation, cell-proliferation, chemokine-production, chemotaxis, cytokine-production, cytokine-secretion, fibroblast-proliferation, germinal-center-formation, hypersensitivity, immune-response, inflammatory-response, interferon-gamma-secretion, isotype-switching, pathogenesis, protein-secretion, secretion, t-cell-differentiation, tolerance-induction, virulence

Quite a number of genes have been found to play important roles in Type 2 Immune Response, such as CD28, CD4, CD80, CD86, CD8A, CTLA4, HLA-DQA1, IFNG, IGHE, IL10, IL13, IL2, IL4, IL5, NOD2, TLR2, TLR4. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.